ERDRP-0519
ERDRP-0519, an orally bioavailable small-molecule Measles virus (MeV) polymerase inhibitor, prevents measles disease in squirrel monkeys (Saimiri sciureus) . ERDRP-0519 inhibits morbilliviruses with nanomolar potency.[1][2][3].
Product Specifications
CAS Number
1374006-96-8
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/erdrp-0519.html
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C(F)(F)F)=NN1C)NC2=CC=C(S(=O)(N3[C@H](CCN4CCOCC4)CCCC3)=O)C=C2
Molecular Formula
C23H30F3N5O4S
Molecular Weight
529.58
References & Citations
[1]Stefanie A Krumm, et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci Transl Med. 2014 Apr 16;6 (232) :232ra52.|[2]Richard K Plemper. Measles Resurgence and Drug Development. Curr Opin Virol. 2020 Apr;41:8-17.|[3]Kevin Wittwer, et al. Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding. Nat Commun. 2021 Sep 2;12 (1) :5233.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SPD-C522w-1mg 1 mg
SARS-CoV-2 Spike RBD Protein, His Tag (BA.2.38/Omicron) (MALS verified)
Sign In for Pricing
View Details 
BNC400818-100 1x 100 µL
CD45RA (PTPRC/818), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
